Review Article
Efficacy and Safety of Zhenwu Decoction in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis
Table 4
Evidence quality for ZWD combined with CWM for the treatment of DN.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; OR: odds ratio; GRADE: working group grades of evidence. High quality: further research is very unlikely to change our confidence in the estimate of the effect. Moderate quality: further research is likely to have an important impact on our confidence in the estimate of the effect and may change the estimate.Low quality: further research is very likely to have an important impact on our confidence in the estimate of the effect and is likely to change the estimate. Very low quality: we are very uncertain about the estimate. Explanations: (a) no blinding. (b) High heterogeneity. (c) < 0.05 in Egger’s test. |